SCD and cancer: Among these isoforms, SCD1 has been most extensively studied and implicated in a wide range of inflammatory and metabolic diseases, including cancer, obesity, cardiac pathologies, atherosclerosis, and autoimmune disorders (reviewed in [13–15]).